Overview

Low-dose Aspirin for Prevention of Adverse Pregnancy Outcomes in Twin Pregnancies

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
Twin pregnancies are associated with increased risk of perinatal adverse outcomes , including preeclampsia , fetal growth restriction , preterm premature rupture of membranes and preterm birth. Low-dose aspirin was recommend by American College of Obstetricians and Gynecologists (ACOG) during pregnancy. In this trial, the investigators suppose that aspirin used in twin-pregnancies could improve adverse pregnancy outcomes.
Phase:
Phase 4
Details
Lead Sponsor:
Ministry of Science and Technology of the People“s Republic of China
Collaborators:
Chongqing Health Center for Women and Children
Chongqing Women and Children's Health Center
Peking University Third Hospital
The third affiliated hospital of Peking University
Treatments:
Aspirin